Respiratory tract antibiotic pulled out
MANILA, Philippines - The Food and Drug Administration (FDA) issued an advisory on the voluntary recall of several batches of a drug used in the treatment of upper and lower respiratory tract infections and other susceptible infections.
The antibiotic in question is Cefaclor monohydrate, 30 mg/ml powder suspension (oral drops) with brand name Ceclobid.
FDA director general Kenneth Hartigan-Go said the affected batches “present safety risk and potential adverse health consequences.”
The recalled batches have registration number DRP-2101 with lot numbers 140350, 140351, 149629, 141041, and 141042, manufactured by El Laboratories, Inc. at 19 North Main Ave., Laguna Technopark, Biñan, Laguna.
Go called on distributors, retailers, hospitals and pharmacies that have the affected products to discontinue further distribution, sale and use. He also ordered all field regulation officers to monitor if the products are still being sold in the market.
- Latest
- Trending
